Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
McGuff Pharmaceuticals
McGuff Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ascor
Ascorbic acid
2017-10-02
2024-2033
Common cold
,
Constipation
,
Methemoglobinemia
,
Penetrating wounds
,
Tyrosinemias
,
Scurvy
,
Hypercholesterolemia
,
Hypophosphatemia
,
Hypertriglyceridemia
,
Peripheral vascular diseases
,
Dermatitis
,
Alcoholic neuropathy
,
Seizures
,
Vitamin a deficiency
,
Hypoparathyroidism
,
Inborn errors metabolism
,
Photosensitivity disorders
,
Thiamine deficiency
,
Folic acid deficiency
,
Rickets
,
Vitamin b 6 deficiency
,
Megaloblastic anemia
,
Vitamin b deficiency
,
Xerophthalmia
,
Wernicke encephalopathy
,
Beriberi
,
Night blindness
,
Riboflavin deficiency
,
Pellagra
,
Chronic kidney failure
,
Cardiovascular diseases
,
Psoriasis
,
Lung neoplasms
,
Crohn disease
,
Skin neoplasms
,
Familial hypophosphatemic rickets
,
Osteoporosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ascorbic acid
keratoconjunctivitis sicca
,
dry eye syndromes
,
healthy volunteers/patients
,
diabetic retinopathy
,
pigmentation
Aglatimagene besadenovec
glioblastoma
,
glioma
,
recurrence
,
renal cell carcinoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
melanoma
,
kidney neoplasms
,
small cell carcinoma
,
neoplasms
,
castration-resistant prostatic neoplasms
,
neoplasm metastasis
,
adenocarcinoma
,
prostatic diseases
,
carcinoma
,
urogenital neoplasms
,
male genital neoplasms
,
neuroendocrine carcinoma
,
neoplasms by site
,
hypersensitivity
,
x-linked bulbo-spinal atrophy
,
glandular and epithelial neoplasms
,
male genital diseases
,
genital diseases
,
endometrial neoplasms
,
prostatic neoplasms
Bevifimod
chronic hepatitis b
,
chronic hepatitis
,
hepatocellular carcinoma
,
liver neoplasms
Doxecitine
non-small-cell lung carcinoma
,
lung neoplasms
,
adenocarcinoma of lung
Retinol
melanoma
,
carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
head and neck neoplasms
,
lung neoplasms
,
respiratory tract diseases
,
germ cell and embryonal neoplasms
,
small cell lung carcinoma
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
adenocarcinoma
,
bronchial diseases
,
neoplasms by histologic type
,
neoplasms by site
,
nerve tissue neoplasms
,
osteoporosis
,
postmenopausal osteoporosis
,
chronic renal insufficiency
,
vitamin d deficiency
,
renal insufficiency
,
kidney transplantation
,
anemia
Taxane
unknown primary neoplasms
,
squamous cell carcinoma of head and neck
,
renal cell carcinoma
,
liver neoplasms
,
biliary tract neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
sex cord-gonadal stromal tumors
,
neuroendocrine carcinoma
,
triple negative breast neoplasms
,
neoplasms
,
ovarian neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
inflammatory breast neoplasms
,
ductal carcinoma breast
,
neoplasm metastasis
,
neoplasms by site
,
lung neoplasms
,
mucinous adenocarcinoma
,
castration-resistant prostatic neoplasms
,
skin diseases
,
breast diseases
,
fallopian tube neoplasms
,
uterine cervical neoplasms
,
carcinoma
,
head and neck neoplasms
,
small cell lung carcinoma
,
peritoneal neoplasms
,
prostatic neoplasms
,
urinary bladder neoplasms
,
respiratory tract diseases
,
germ cell and embryonal neoplasms
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
bronchial diseases
,
neoplasms by histologic type
,
nerve tissue neoplasms
,
patient preference
,
ovarian epithelial carcinoma
,
lobular carcinoma
,
endometrial neoplasms
,
breast neoplasms
,
non-small-cell lung carcinoma
,
adenocarcinoma
,
adenocarcinoma of lung
,
colonic neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use